Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Dexamethasone × Clear all

NCT06136650 2026-03-09

MK-5684-004

Phase 3 Recruiting

Prostatic Neoplasms

NCT06104449 2026-03-06

MK-5684-005

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT06136598 2026-02-17

MK-5684-001

Phase 1 Active not recruiting

Prostatic Neoplasms

NCT04729114 2026-02-04

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Phase 1 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT01867710 2019-07-05

Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

Phase 2 Completed

164 enrolled 22 charts

Hyperaldosteronism, Prostatic Neoplasms

NCT02441894 2017-01-24

PEGAZUS

Phase 4 Completed

Prostatic Neoplasms

NCT01188187 2016-10-14

SYNERGY

Phase 3 Completed

Prostatic Neoplasms

NCT00473746 2014-04-29

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Phase 1/2 Completed

66 enrolled 22 charts

Prostatic Neoplasms

NCT00473512 2014-03-27

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Phase 1/2 Completed

54 enrolled 20 charts

Prostatic Neoplasms